BiotechTube
NE Scientific

NE Scientific

Boston, United States· Est.
ne-scientific.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

NE Scientific is a pioneer in real-time simulation software for percutaneous ablation, a minimally invasive cancer treatment. The company addresses a critical clinical gap where 10-30% of procedures leave untreated tumor tissue due to a lack of intraoperative guidance, leading to recurrence. Its core technology uses GPU acceleration to model ablation physics (RFA, MWA, Cryo, etc.) in real-time, overlaying the predicted treatment zone on live imaging to guide physicians. Backed by over $1.8M in NCI SBIR grants and industry awards from Johnson & Johnson and NVIDIA, NE Scientific has progressed its technology into clinical trials.

Oncology

Technology Platform

GPU-accelerated real-time software for simulating the physics of multiple ablation modalities (RFA, MWA, Cryoablation, LSA, IRE) to provide intraoperative visual guidance during percutaneous tumor ablation procedures.

Opportunities

The growing global tumor ablation market and the high 10-30% incomplete treatment rate create a significant addressable need for precision guidance software.
The platform's applicability across multiple ablation energy types (RFA, MWA, Cryo, etc.) and cancer indications allows for broad market penetration and reduces technology obsolescence risk.

Risk Factors

Clinical validation risk that the simulation does not translate to improved patient outcomes in pivotal trials.
Commercialization risk in integrating into hospital workflows and competing against potential integrated solutions from large ablation device or imaging companies.
Dependence on grant funding necessitates a successful transition to equity financing.

Competitive Landscape

Direct competitors may include other startups in surgical simulation or AI-guided intervention, but NE Scientific appears to be a pioneer in real-time physics-based ablation modeling. Larger competitive threats come from established ablation device manufacturers (e.g., Medtronic, Boston Scientific) who could develop similar guidance features in-house, and from broader AI imaging analytics companies moving into procedural support.

More companies in United States →